Antibiotic Use & Antibiotic Resistance – The Emergence of Carbapenem Resistance in Canada and Globally: Can We Predict Future Spread from Past Experiences?
Allan Ronald, OC, MD, FRSC, FRCPC
Senior Scientific Advisor, National Collaborating Centre for Infectious Diseases
Michael Mulvey PhD, ARMCCM
Chief, Antimicrobial Resistance and Nosocomial Infections, National Microbiology Laboratory
Abstract: Antibiotic resistance affects everyone – from patients and parents, to human and animal health providers and the food animal sectors. We understand the challenges of fighting resistant infections and the connection between antibiotic use and resistance. This colloquium will ask health practitioners and researchers to consider “what’s my role”?
The presentation will explore antimicrobial use and resistance from two different perspectives. First, Dr. Allan Ronald, Senior Scientific Advisor at the National Collaborating Centre for Infectious Diseases (NCCID), will provide a brief overview NCCID’s work in AMR, as well as Antibiotic Awareness Week and the joint activities of health-related organizations across Canada to increase awareness. This will be followed by a keynote presentation by Dr. Michael Mulvey, Chief, Antimicrobial Resistance and Nosocomial Infections (ARNI), who will discuss the emergence of carbapenem-resistance in Enterobacteriaciae and how we will begin to see this virtually untreatable pathogen very soon in our communities.
A surprise treat will be served during the colloquium
All are welcome to attend!